Rescue of Defective Electroretinographic Responses in Dp71-Null Mice With AAV-Mediated Reexpression of Dp71.


Journal

Investigative ophthalmology & visual science
ISSN: 1552-5783
Titre abrégé: Invest Ophthalmol Vis Sci
Pays: United States
ID NLM: 7703701

Informations de publication

Date de publication:
07 02 2020
Historique:
entrez: 13 2 2020
pubmed: 13 2 2020
medline: 14 4 2020
Statut: ppublish

Résumé

To study the potential effect of a gene therapy, designed to rescue the expression of dystrophin Dp71 in the retinas of Dp71-null mice, on retinal physiology. We recorded electroretinograms (ERGs) in Dp71-null and wild-type littermate mice. In dark-adapted eyes, responses to flashes of several strengths were measured. In addition, flash responses on a 25-candela/square meters background were measured. On- and Off-mediated responses to sawtooth stimuli and responses to photopic sine-wave modulation (3-30 Hz) were also recorded. After establishing the ERG phenotype, the ShH10-GFP adeno-associated virus (AAV), which has been previously shown to target specifically Müller glial cells (MGCs), was delivered intravitreously with or without (sham therapy) the Dp71 coding sequence under control of a CBA promoter. ERG recordings were repeated three months after treatment. Real-time quantitative PCR and Western blotting analyses were performed in order to quantify Dp71 expression in the retinas. Dp71-null mice displayed reduced b-waves in dark- and light-adapted flash ERGs and smaller response amplitudes to photopic rapid-on sawtooth modulation and to sine-wave stimuli. Three months after intravitreal injections of the ShH10-GFP-2A-Dp71 AAV vector, ERG responses were completely recovered in treated eyes of Dp71-null mice. The functional rescue was associated with an overexpression of Dp71 in treated retinas. The present results show successful functional recovery accompanying the reexpression of Dp71. In addition, this experimental model sheds light on MGCs influencing ERG components, since previous reports showed that aquaporin 4 and Kir4.1 channels were mislocated in MGCs of Dp71-null mice, while their distribution could be normalized following intravitreal delivery of the same ShH10-GFP-2A-Dp71 vector.

Identifiants

pubmed: 32049345
pii: 2761233
doi: 10.1167/iovs.61.2.11
pmc: PMC7326481
doi:

Substances chimiques

Dystrophin 0
apo-dystrophin 1 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

11

Références

Hum Mol Genet. 2016 Jul 15;25(14):3070-3079
pubmed: 27288449
Nature. 1986 Dec 4-10;324(6096):466-8
pubmed: 2431322
FEBS Lett. 1993 Aug 9;328(1-2):197-202
pubmed: 8344426
JCI Insight. 2018 Jan 25;3(2):
pubmed: 29367457
Glia. 2014 Mar;62(3):468-76
pubmed: 24382652
Mol Ther. 2010 Sep;18(9):1683-8
pubmed: 20588257
Adv Exp Med Biol. 2010;664:671-8
pubmed: 20238072
Ophthalmology. 2019 Jun;126(6):801-810
pubmed: 30711604
PLoS One. 2009 Oct 07;4(10):e7329
pubmed: 19809515
Hum Gene Ther Methods. 2012 Feb;23(1):18-28
pubmed: 22428977
J Neurosci. 2000 Aug 1;20(15):5733-40
pubmed: 10908613
Vision Res. 1968 Jun;8(6):633-77
pubmed: 4978009
J Neurophysiol. 1994 Jul;72(1):96-105
pubmed: 7965036
Exp Eye Res. 1992 Apr;54(4):481-90
pubmed: 1623934
Glia. 2013 May;61(5):651-78
pubmed: 23440929
Neurochem Int. 2019 Oct;129:104489
pubmed: 31199961
Invest Ophthalmol Vis Sci. 2017 Feb 1;58(2):1237-1245
pubmed: 28241311
Int J Psychophysiol. 1997 Jun;26(1-3):229-36
pubmed: 9203005
Exp Eye Res. 2009 Jun 15;89(1):119-22
pubmed: 19450458
Glia. 2006 Jan 15;53(2):124-31
pubmed: 16206160
Biochem J. 1990 Dec 1;272(2):557-60
pubmed: 2176467
PLoS One. 2009 Oct 14;4(10):e7467
pubmed: 19826483
Br J Ophthalmol. 1975 Nov;59(11):649-56
pubmed: 1203221
Invest Ophthalmol Vis Sci. 2016 Jul 1;57(8):3581-7
pubmed: 27388051
PLoS One. 2018 Feb 23;13(2):e0193280
pubmed: 29474462
Hum Mol Genet. 1992 May;1(2):103-9
pubmed: 1301145
Diabetes. 2014 Nov;63(11):3926-37
pubmed: 24947354
Doc Ophthalmol. 2015 Feb;130(1):1-12
pubmed: 25502644
Invest Ophthalmol Vis Sci. 2011 Oct 07;52(11):7901-8
pubmed: 21896869
Graefes Arch Clin Exp Ophthalmol. 2007 May;245(5):627-36
pubmed: 17219109
Neurosci Lett. 1981 Feb 6;21(3):307-12
pubmed: 7219877
Glia. 2008 Apr 15;56(6):597-610
pubmed: 18286645
J Physiol. 2011 Apr 1;589(Pt 7):1681-9
pubmed: 21300747
Curr Protoc Mol Biol. 2007 Apr;Chapter 16:Unit 16.25
pubmed: 18265393
Hum Mol Genet. 1998 Sep;7(9):1385-91
pubmed: 9700191
Glia. 2002 Sep;39(3):292-303
pubmed: 12203395
PLoS One. 2013;8(1):e54146
pubmed: 23335994
PLoS One. 2008 Aug 10;4(8):e6574
pubmed: 19649270
Arch Ophthalmol. 1978 May;96(5):878-9
pubmed: 655925
Nat Med. 2015 Mar;21(3):270-5
pubmed: 25642938
Prog Retin Eye Res. 2016 Mar;51:1-40
pubmed: 26113209
Nature. 1984 May 10-16;309(5964):155-7
pubmed: 6717594
J Int Med Res. 2011;39(2):464-79
pubmed: 21672350
J Neurosci. 1998 Jun 1;18(11):4022-8
pubmed: 9592083
Hum Genet. 1999 Jul-Aug;105(1-2):2-9
pubmed: 10480348
Hum Mol Genet. 1995 May;4(5):837-42
pubmed: 7633443
Invest Ophthalmol Vis Sci. 1999 Jun;40(7):1520-9
pubmed: 10359335
J Neurosci. 1993 Aug;13(8):3333-45
pubmed: 8340811
Mol Ther. 2009 Mar;17(3):463-71
pubmed: 19066593
Hum Mol Genet. 2003 Jul 1;12(13):1543-54
pubmed: 12812982
J Neurophysiol. 1984 Jan;51(1):164-82
pubmed: 6319623
Ophthalmology. 1994 May;101(5):856-65
pubmed: 8190471
J Neurosci. 2002 Jun 1;22(11):4321-7
pubmed: 12040037
Hum Mol Genet. 1995 Sep;4(9):1475-83
pubmed: 8541829
J Biol Chem. 2013 Mar 8;288(10):7420-9
pubmed: 23339194
Doc Ophthalmol. 2009 Dec;119(3):181-97
pubmed: 19760280
J Neurophysiol. 1970 May;33(3):323-41
pubmed: 5439340
Vis Neurosci. 1995 Sep-Oct;12(5):837-50
pubmed: 8924408
J Comp Neurol. 1979 Nov 15;188(2):225-44
pubmed: 500857
Eur J Hum Genet. 2016 Apr;24(4):562-8
pubmed: 26081639
J Cell Sci. 2000 Oct;113 Pt 19:3409-17
pubmed: 10984432
J Neurosci. 1985 Aug;5(8):2225-39
pubmed: 3874934
Invest Ophthalmol Vis Sci. 2002 Feb;43(2):573-9
pubmed: 11818406
Ophthalmic Res. 2014;51(4):196-203
pubmed: 24662427
Exp Eye Res. 2016 May;146:259-68
pubmed: 27018215
Invest Ophthalmol Vis Sci. 2004 Dec;45(12):4477-83
pubmed: 15557457
Neurosci Lett. 2007 Jun 27;421(2):132-6
pubmed: 17566653
Mol Ther Nucleic Acids. 2017 Sep 15;8:144-157
pubmed: 28918017
Invest Ophthalmol Vis Sci. 1993 Dec;34(13):3646-52
pubmed: 8258524
Proc Natl Acad Sci U S A. 1990 Mar;87(6):2117-21
pubmed: 2107544
Arch Ophthalmol. 1968 Jul;80(1):58-67
pubmed: 5660019
Neuroscience. 1981;6(4):679-88
pubmed: 6165924
Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7506-10
pubmed: 1380160
Invest Ophthalmol Vis Sci. 2016 Oct 1;57(13):5788-5798
pubmed: 27792813
Hum Gene Ther. 2017 Dec 7;:
pubmed: 29212391
Mol Genet Metab. 1999 Feb;66(2):100-10
pubmed: 10068512
Proc Natl Acad Sci U S A. 1994 May 24;91(11):5153-7
pubmed: 8197199
Prog Neurobiol. 1997 Dec;53(5):547-60
pubmed: 9421835
J Clin Invest. 1994 Jun;93(6):2425-30
pubmed: 8200977
Glia. 2016 May;64(5):716-29
pubmed: 26711882
Doc Ophthalmol. 1999;98(3):207-32
pubmed: 10945442
Invest Ophthalmol Vis Sci. 1995 Feb;36(2):462-6
pubmed: 7843915
J Comp Neurol. 2008 Oct 10;510(5):484-96
pubmed: 18671302
Can J Physiol Pharmacol. 1987 May;65(5):1028-32
pubmed: 2441827
Hum Mol Genet. 1997 Dec;6(13):2195-203
pubmed: 9361023
Science. 1984 Sep 14;225(4667):1174-5
pubmed: 6474173
Invest Ophthalmol Vis Sci. 2013 May 07;54(5):3195-204
pubmed: 23572107
Glia. 2017 Apr;65(4):533-568
pubmed: 27767232
Biol Pharm Bull. 2019;42(3):343-347
pubmed: 30828065

Auteurs

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH